Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › EMA confirms serious risks associated with MS medicine Zinbryta

  • MS Medications

    EMA confirms serious risks associated with MS medicine Zinbryta

    Posted by MS News Today Moderator on May 25, 2018 at 11:08 am

    The European Medicines Agency (EMA) has confirmed severe risks associated with the multiple sclerosis therapy Zinbryta (daclizumab). These risks may include developing severe and potentially fatal immune reactions in the brain, liver and other organs.

    Read more about this medicine and its risks in this MultipleSclerosisNewsToday.com article: European EMA Confirms Severe Risks Associated with MS Medicine Zinbryta

    Did you know about the risks of this medicine? Have you ever been treated with Zinbryta?

    ed-tobias replied 5 years, 11 months ago 2 Members · 1 Reply
  • 1 Reply

  • ed-tobias

    Member
    May 25, 2018 at 2:52 pm

    Note that the manufacturers of Zinbryta withdrew the medication from the European market two months ago.

    Ed

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .